Nucleotide substitution: G?A.
Base change CGC->CAC.
Fmr1R115H.EP3517 carries both the P{EP} insertion present in the progenitor allele and the amino acid replacement in the Fmr1 coding region.
Amino acid replacement: R115H.
G10105871A
G?A
R115H | Fmr1-PA; R115H | Fmr1-PB; R115H | Fmr1-PC; R115H | Fmr1-PD; R77H | Fmr1-PE; R77H | Fmr1-PF; R163H | Fmr1-PG; R163H | Fmr1-PH; R77H | Fmr1-PI; R115H | Fmr1-PJ; R115H | Fmr1-PK
R115H
CyfipUAS.cSa, Fmr1R115H.EP3517, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype
CyfipUAS.cSa, Fmr1R115H.EP3517, Scer\GAL4elav.PU has neuromuscular junction phenotype
Co-overexpression of Fmr1R115H.EP3517 and Sra-1Scer\UAS.cSa using Scer\GAL4elav.PU results in a significant neuromuscular junction overgrowth phenotype.
Selected as: A mutation that suppresses the lethality caused when a Scer\GAL4 driver is used to overexpress Fmr1 from the P{EP}Fmr1EP3517 insertion.